Breast Cancer
📧 Sign up to get email alerts when something new happens for Breast Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-01-09Clinical Trial Update: Effect of Physical Training Program on the Exercise Adherence for Breast Cancer Survivor [NA]
This document reports the completion of a clinical trial evaluating a physical training program to improve exercise adherence in breast canc…
-
CLINICAL_TRIALS trial_result · 2026-01-08Clinical Trial Update: Evaluating the Dose Timing (Morning vs Evening) of Endocrine Therapy and Its Effects on Tolerability and Compliance [Phase 4]
Phase 4 trial compares morning versus evening dosing of endocrine therapy in breast cancer and reports findings on tolerability and patient …
-
CLINICAL_TRIALS trial_result · 2026-01-08Clinical Trial Update: Improving Utilization of Supplemental Breast MRI Screening for Women With Extremely Dense Breasts [NA]
The clinical trial examining how to improve use of supplemental breast MRI screening in women with extremely dense breasts has completed.
-
CLINICAL_TRIALS trial_result · 2026-01-08Clinical Trial Update: Effect of Midazolam as Premedication in Patients Undergoing Breast Conservation Study
The document notes the completion of a trial evaluating midazolam as premedication in patients undergoing breast-conserving surgery who have…
-
CLINICAL_TRIALS trial_result · 2026-01-08Clinical Trial Update: Role of Preoperative Tapentadol in Reduction of Perioperative Analgesic Requirement After Breast Conservative Surgery in Cancer Patients. [NA]
A completed clinical trial evaluating preoperative tapentadol to reduce perioperative analgesic requirements after breast-conserving surgery…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2026-01-07Clinical Trial Update: A Phase 1 Study of [225Ac]-FPI-1434 Injection [Phase 1]
A Phase 1 study of [225Ac]-FPI-1434 injection sponsored by Fusion Pharmaceuticals has been terminated.
-
CLINICAL_TRIALS trial_result · 2026-01-06Clinical Trial Update: Omission of Surgery in Clinically Low-risk HER2positive Breast Cancer With High HER2 Addiction and a Complete Response Following Standard Anti-HER2-based Neoadjuvant Therapy [Phase 2]
Phase 2 trial evaluating whether surgery can be omitted in clinically low-risk HER2-positive breast cancer patients who achieve complete res…
-
CLINICAL_TRIALS trial_result · 2026-01-06Clinical Trial Update: Evaluation of a Cone-beam CT Scanner for Image Guided Radiotherapy [NA]
This clinical trial update reports the completed status and posted results for evaluating a cone-beam CT scanner used in image-guided radiot…
-
CLINICAL_TRIALS trial_result · 2026-01-06Clinical Trial Update: A Study of Lutetium [177Lu]-BL-ARC001 in Patients With Locally Advanced or Metastatic Lung Cancer, Breast Cancer, Head and Neck Squamous Cell Carcinoma and Other Solid Tumors [Phase 1]
This is an update on an ongoing Phase 1 clinical trial evaluating Lutetium-177Lu-BL-ARC001 in patients with lung cancer, breast cancer, and …
-
CLINICAL_TRIALS trial_result · 2026-01-05Clinical Trial Update: A Study to Compare the Effectiveness of Two Types of Ultrasound Technologies in Women Who Have Had Breast Cancer [NA]
A completed study comparing two ultrasound technologies in women who have had breast cancer.
-
CLINICAL_TRIALS trial_result · 2026-01-05Clinical Trial Update: Effects of a Single Chemotherapy Administration on Skeletal Muscle of Breast Cancer Patients: Comparison of Paclitaxel vs Paclitaxel + Trastuzumab vs Paclitaxel + Carboplatine: the PROTECT-06 Bis Study
This clinical trial update reports the termination of the PROTECT-06 Bis study comparing paclitaxel alone, paclitaxel with trastuzumab, and …
-
CLINICAL_TRIALS trial_result · 2026-01-02Clinical Trial Update: Online Dietary and Resistance Training to Improve Physical Function in Older Cancer Survivors, E-PROOF Trial [NA]
The E-PROOF trial, evaluating online dietary guidance and resistance training to improve physical function in older cancer survivors, has co…
-
CLINICAL_TRIALS trial_result · 2026-01-02Clinical Trial Update: Analgesia Nociception Index (ANI) After Unilateral Radical Mastectomy as an Evaluation of Paravertebral Block Failure
Completed clinical trial evaluating Analgesia Nociception Index after unilateral radical mastectomy to assess paravertebral block failure.
-
CLINICAL_TRIALS trial_result · 2026-01-02Clinical Trial Update: Study of Anxiety After a Session of Energy Resonance by Cutaneous Stimulation [NA]
The clinical trial update indicates that the study assessing anxiety after a session of energy resonance by cutaneous stimulation in patient…
-
CLINICAL_TRIALS trial_result · 2026-01-02Clinical Trial Update: Alpelisib (BYL719) in Combination With Continued Endocrine Therapy Following Progression on Endocrine Therapy in Hormone Receptor Positive, HER2 Negative, PIK3CA Mutant Metastatic Breast Cancer [Phase 2]
Phase 2 trial evaluating alpelisib in combination with continued endocrine therapy after progression in HR-positive, HER2-negative, PIK3CA-m…
-
CLINICAL_TRIALS trial_result · 2026-01-02Clinical Trial Update: Study of Pembrolizumab Plus Fulvestrant in Hormone Receptor Positive, HER-2 Negative Advanced/Metastatic Breast Cancer Patients [Phase 2]
Phase 2 study evaluating pembrolizumab plus fulvestrant in hormone receptor-positive, HER-2-negative advanced/metastatic breast cancer; the …
-
CLINICAL_TRIALS trial_result · 2026-01-02Clinical Trial Update: Impact of Adapted Physical Activity on Cognitive Functions in Breast Cancer [NA]
The completed trial assessed whether adapted physical activity improves cognitive function in breast cancer patients.
-
CLINICAL_TRIALS trial_result · 2025-12-31Clinical Trial Update: Oncoplastic Partial Mastectomy With Intraoperative Radiation Therapy (IORT) in Early Stage Breast Cancer Patients With Prior History of Chest Wall Radiation. [NA]
Clinical trial NCT05289466 evaluating oncoplastic partial mastectomy with intraoperative radiation therapy for early-stage breast cancer in …
-
CLINICAL_TRIALS trial_result · 2025-12-31Clinical Trial Update: A Multilevel Intervention to Improve Timely Cancer Detection and Treatment Initiation [Phase 2]
This Phase 2 clinical trial update describes a multilevel intervention to improve timely cancer detection and initiation of treatment; the s…
-
CLINICAL_TRIALS trial_result · 2025-12-31Clinical Trial Update: Tucatinib, Trastuzumab, and Capecitabine With SRS for Brain Metastases From HER-2 Positive Breast Cancer [Phase 1]
A Phase 1 trial evaluating tucatinib, trastuzumab, and capecitabine with stereotactic radiosurgery for brain metastases in HER2-positive bre…
-
CLINICAL_TRIALS trial_result · 2025-12-30Clinical Trial Update: Testing the Drug Atezolizumab or Placebo With Usual Therapy in First-Line HER2-Positive Metastatic Breast Cancer [Phase 3]
A Phase 3 trial testing atezolizumab or placebo with standard therapy as first-line treatment for HER2-positive metastatic breast cancer has…
-
CLINICAL_TRIALS trial_result · 2025-12-30Clinical Trial Update: Validation of Molecular Diagnostic Assays to Detect Cancer Biomarkers in Blood & Primary Tumor in ER+/HER2- MBC
A completed study validating molecular diagnostic assays to detect cancer biomarkers in blood and primary tumors from patients with ER+/HER2…
-
CLINICAL_TRIALS trial_result · 2025-12-30Clinical Trial Update: Contrast-enhanced Ultrasound for Sentinel Node Detection [Phase 2, Phase 3]
A Phase 2/Phase 3 clinical trial sponsored by The Netherlands Cancer Institute is evaluating contrast-enhanced ultrasound for sentinel lymph…
-
CLINICAL_TRIALS trial_result · 2025-12-30Clinical Trial Update: Breast Cancer Pre-habilitation and Prospective Surveillance to Prevent, Detect, and Optimize Physical and Function [NA]
A completed Northwestern University clinical trial examining breast cancer prehabilitation and prospective surveillance to prevent, detect, …
-
CLINICAL_TRIALS trial_result · 2025-12-29Clinical Trial Update: A First-in-Human, Phase 1 Study of JAB-3312 in Adult Patients With Advanced Solid Tumors [Phase 1]
First-in-human Phase 1 study of JAB-3312 in adults with advanced solid tumors has been completed, evaluating multiple tumor indications.